Scientific Sessions 2025  /  Hottest Clinical Trials in Valvular Heart Disease: Key Insights from Late-Breaking Studies  /  Valvular Heart Disease Clinical Trials: What Does the Future Hold?
Logo

American Heart Association

  129
  0

Final ID:

Valvular Heart Disease Clinical Trials: What Does the Future Hold?

  • Enriquez-sarano, Maurice  ( Minneapolis Heart Institute , Minneapolis , Minnesota , United States )
  • Mack, Michael  ( Baylor heart Hospital , Plano , Texas , United States )
  • Ogara, Patrick  ( BRIGHAM AND WOMENS HOSPITAL , Boston , Massachusetts , United States )
  • Leon, Martin  ( COLUMBIA UNIVERSITY MEDICAL CTR , New York , New York , United States )
    • Author Disclosures:
    Maurice Enriquez-Sarano: DO have relevant financial relationships ; Consultant:HighLife:Active (exists now) ; Consultant:Corcym:Active (exists now) | Michael Mack: DO have relevant financial relationships ; Research Funding (PI or named investigator):Edwards Lifesciences:Active (exists now) ; Other (please indicate in the box next to the company name):Carmat- Corporate board:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) | Patrick OGara: DO NOT have relevant financial relationships | Martin Leon: DO have relevant financial relationships ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Individual Stocks/Stock Options:Ancora:Past (completed) ; Individual Stocks/Stock Options:Cathworks:Active (exists now) ; Research Funding (PI or named investigator):Edwards:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Hottest Clinical Trials in Valvular Heart Disease: Key Insights from Late-Breaking Studies

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
TAVR UNLOAD Trial: TAVR in Patients with Systolic Heart Failure and Moderate Aortic Stenosis

Elmariah Sammy, Leon Martin, Van Mieghem Nicolas, Hahn Rebecca

TAVR vs. SAVR in Low-Risk Aortic Stenosis Patients: 5-Year Outcomes Unveiled for Evolut Low-Risk

Reardon Michael, Forrest John, Popma Jeffrey, Tchetche Didier

More abstracts from these authors:
Heart Innovations on the Horizon: Shaping the Future of Valvular Disease Treatment

Enriquez-sarano Maurice, Leon Martin, Mack Michael, Adams David, Kapadia Samir

What Should the Future Valvular Guidelines Change for Aortic Stenosis?

Ogara Patrick, Leon Martin, Bonow Robert, Mack Michael, Thompson Annemarie

You have to be authorized to contact abstract author. Please, Login
Not Available